Pentagon Restarts Controversial Testosterone Screening for Service Members

On Thursday, the Pentagon announced that it is moving ahead with a mandatory testosterone‑deficiency testing program for U.S. service members who are 30 years old or older. The decision effectively ends a short‑lived suspension that was put in place earlier this month to allow officials to “review and update” the guidance.

The policy, first rolled out by Defense Secretary Pete Hegseth in July, requires men in the specified age bracket to undergo blood tests that check for low testosterone levels. Women, according to the original directive, would be screened through a questionnaire and could be referred for treatment if hormonal imbalances were suspected.

“Effective immediately, this guidance addresses male testosterone deficiency, establishing uniform screening and treatment pathways,” Pentagon spokesperson Sean Parnell said in a statement. The wording is deliberately clinical, but the rollout feels anything but ordinary – especially after the sudden pause that left many service members and their families wondering whether the whole thing would be scrapped.

Medical experts have been fairly vocal about their concerns. Some argue that prescribing testosterone without a clear, medically‑necessary indication could open the door to side‑effects such as reduced fertility, cardiovascular issues, or mood disturbances. Others worry the program could become a de‑facto fitness test, pressuring soldiers to maintain a certain hormonal profile rather than focusing on actual combat readiness.

“It’s a slippery slope,” one veteran‑turned‑physician told us, “when you start treating a hormone like a performance enhancer rather than a health issue.” The comment may sound a bit dramatic, but the underlying worry is shared across several professional bodies, including the American College of Physicians, which has warned that broad‑scale testosterone supplementation can be more harmful than helpful if not carefully managed.

Supporters of the initiative, however, point to data suggesting that low testosterone can affect energy levels, mood, and even muscle mass – all factors that could, in theory, influence a soldier’s ability to perform demanding tasks. Secretary Hegseth has repeatedly framed the policy as a way to “optimize force health and readiness,” arguing that a healthier soldier pool ultimately benefits national security.

Still, the timing is odd. The temporary suspension came just weeks after the program’s launch, and the Pentagon has been vague about what, if any, changes were made during the pause. Critics say that lack of transparency only fuels suspicion, especially when it comes to something as personal and potentially intrusive as hormone testing.

As the program rolls out again, service members will receive new orders outlining the testing schedule, consent forms, and information about follow‑up care. Whether the policy will stand the test of time – or be revised once more – remains to be seen. For now, the conversation continues, with health professionals, military leaders, and service members all weighing in on a matter that sits at the crossroads of medicine, ethics, and national defense.